SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sumana Devata, Ryan A. Wilcox, Cutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents, American Journal of Clinical Dermatology, 2016,

    CrossRef

  2. 2
    Ryan A. Wilcox, Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management, American Journal of Hematology, 2016, 91, 1
  3. 3
    Pier Luigi Zinzani, Vijayveer Bonthapally, Dirk Huebner, Richard Lutes, Andy Chi, Stefano Pileri, Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Cutaneous T-cell lymphomas, Critical Reviews in Oncology/Hematology, 2016, 99, 228

    CrossRef

  4. 4
    Iván P. Uray, Ethan Dmitrovsky, Powel H. Brown, Retinoids and rexinoids in cancer prevention: from laboratory to clinic, Seminars in Oncology, 2016, 43, 1, 49

    CrossRef

  5. 5
    Bláithín Moriarty, Sean Whittaker, Diagnosis, prognosis and management of erythrodermic cutaneous T-cell lymphoma, Expert Review of Hematology, 2015, 8, 2, 159

    CrossRef

  6. 6
    Jahaira Lopez-Pastrana, Ying Shao, Valeria Chernaya, Hong Wang, Xiao-Feng Yang, Epigenetic enzymes are the therapeutic targets for CD4+CD25+/highFoxp3+ regulatory T cells, Translational Research, 2015, 165, 1, 221

    CrossRef

  7. 7
    Maxim Polansky, Rakhshandra Talpur, Seema Daulat, Chitra Hosing, Bouthaina Dabaja, Madeleine Duvic, Long-Term Complete Responses to Combination Therapies and Allogeneic Stem Cell Transplants in Patients With Sézary Syndrome, Clinical Lymphoma Myeloma and Leukemia, 2015, 15, 5, e83

    CrossRef

  8. 8
    Alessandra di Masi, Loris Leboffe, Elisabetta De Marinis, Francesca Pagano, Laura Cicconi, Cécile Rochette-Egly, Francesco Lo-Coco, Paolo Ascenzi, Clara Nervi, Retinoic acid receptors: From molecular mechanisms to cancer therapy, Molecular Aspects of Medicine, 2015, 41, 1

    CrossRef

  9. 9
    Auris O. Huen, Ellen J. Kim, The Role of Systemic Retinoids in the Treatment of Cutaneous T-Cell Lymphoma, Dermatologic Clinics, 2015, 33, 4, 715

    CrossRef

  10. 10
    Natalie Spaccarelli, Alain H. Rook, The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma, Dermatologic Clinics, 2015, 33, 4, 731

    CrossRef

  11. You have free access to this content11
    Ryan A. Wilcox, Cutaneous T-cell lymphoma: 2014 Update on diagnosis, risk-stratification, and management, American Journal of Hematology, 2014, 89, 8
  12. 12
    D. J. Straus, M. Duvic, S. M. Horwitz, K. Hymes, A. Goy, F. J. Hernandez-Ilizaliturri, T. Feldman, B. Wegner, P. L. Myskowski, Final results of phase II trial of doxorubicin HCl liposome injection followed by bexarotene in advanced cutaneous T-cell lymphoma, Annals of Oncology, 2014, 25, 1, 206

    CrossRef

  13. 13
    Sarah I. Jawed, Patricia L. Myskowski, Steven Horwitz, Alison Moskowitz, Christiane Querfeld, Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome), Journal of the American Academy of Dermatology, 2014, 70, 2, 223.e1

    CrossRef

  14. 14
    Gregory M. Cote, Edwin Choy, Role of Epigenetic Modulation for the Treatment of Sarcoma, Current Treatment Options in Oncology, 2013, 14, 3, 454

    CrossRef

  15. 15
    Courtney R. Schadt, Topical and oral bexarotene, Dermatologic Therapy, 2013, 26, 5
  16. 16
    J.J. Scarisbrick, S. Morris, R. Azurdia, T. Illidge, E. Parry, R. Graham-Brown, R. Cowan, E. Gallop-Evans, R. Wachsmuth, M. Eagle, A.S. Wierzbicki, H. Soran, S. Whittaker, E.M. Wain, U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma, British Journal of Dermatology, 2013, 168, 1
  17. 17
    Uwe Wollina, Cutaneous T cell lymphoma: update on treatment, International Journal of Dermatology, 2012, 51, 9
  18. 18
    Andrea Gulia, Cesare Massone, Primary cutaneous T-cell lymphomas, Journal of the Egyptian Womenʼs Dermatologic Society, 2012, 9, 1, 1

    CrossRef

  19. You have free access to this content19
    Ryan A. Wilcox, Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management, American Journal of Hematology, 2011, 86, 11
  20. 20
    Rakhshandra Talpur, Marie Francis Demierre, Larisa Geskin, Elma Baron, Silvina Pugliese, Kelley Eubank, John A. Zic, Donald R. Miller, Michael Tharp, Kimberly Bohjanen, Madeleine Duvic, Multicenter Photopheresis Intervention Trial in Early-Stage Mycosis Fungoides, Clinical Lymphoma Myeloma and Leukemia, 2011, 11, 2, 219

    CrossRef

  21. 21
    Elise A. Olsen, Alain H. Rook, John Zic, Youn Kim, Pierluigi Porcu, Christiane Querfeld, Gary Wood, Marie-France Demierre, Mark Pittelkow, Lynn D. Wilson, Lauren Pinter-Brown, Ranjana Advani, Sareeta Parker, Ellen J. Kim, Jacqueline M. Junkins-Hopkins, Francine Foss, Patrick Cacchio, Madeleine Duvic, Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC), Journal of the American Academy of Dermatology, 2011, 64, 2, 352

    CrossRef

  22. 22
    Joseph R. Carver, Supportive Oncology, 2011,

    CrossRef

  23. 23
    Liyan Qu, Xiuwen Tang, Bexarotene: a promising anticancer agent, Cancer Chemotherapy and Pharmacology, 2010, 65, 2, 201

    CrossRef

  24. 24
    Ajith P. Kannangara, Denise Levitan, Alan B. Fleischer, Evaluation of the efficacy of the combination of oral bexarotene and methotrexate for the treatment of early stage treatment-refractory cutaneous T-cell lymphoma, Journal of Dermatological Treatment, 2009, 20, 3, 169

    CrossRef

  25. 25
    Joslyn S Kirby, Ellen J Kim, Alain H Rook, Therapy of Sézary syndrome, Expert Review of Dermatology, 2009, 4, 6, 567

    CrossRef

  26. 26
    Jennifer M Gardner, Katherine G Evans, Amy Musiek, Alain H Rook, Ellen J Kim, Update on treatment of cutaneous T-cell lymphoma, Current Opinion in Oncology, 2009, 21, 2, 131

    CrossRef

  27. You have free access to this content27
    Current Awareness in Hematological Oncology, Hematological Oncology, 2008, 26, 1
  28. 28
    M. Bagot, Linfomas T cutáneos, EMC - Dermatología, 2008, 42, 4, 1

    CrossRef

  29. 29
    M. Bagot, Lymphomes T cutanés, EMC - Dermatologie, 2008, 3, 3, 1

    CrossRef

  30. 30
    Steven M. Horwitz, Novel Therapies for Cutaneous T-Cell Lymphomas, Clinical Lymphoma and Myeloma, 2008, 8, S187

    CrossRef

  31. 31
    Evangelia Papadavid, Christina Antoniou, Vassiliki Nikolaou, Marina Siakantaris, Theodoros P Vassilakopoulos, Alexandros Stratigos, Nikolaos Stavrianeas, Andreas Katsambas, Safety and Efficacy of Low-Dose Bexarotene and PUVA in the Treatment of Patients with Mycosis Fungoides, American Journal of Clinical Dermatology, 2008, 9, 3, 169

    CrossRef

  32. 32
    Joseph R. Carver, Chaitali J. Desai, Cardiovascular Toxicity of Antitumor Drugs: Dimension of the Problem in Adult Settings,
  33. 33
    Mycosis Fungoides,
  34. 34
    Fiona Child, Sean Whittaker, Primary Cutaneous T-cell Lymphoma,
  35. 35
    Marcia I. Dawson, Retinoids, Burger's Medicinal Chemistry and Drug Discovery,